Leinco Technologies Acquires BioClin, Inc.’s Essential IVD Raw Material Antibody Clones, Bolstering Leinco’s IVD Raw Material Catalog Business
Saint Louis, MO – July 7, 2025 Leinco Technologies, a [...]
Leinco Technologies Launches Groundbreaking ADAPT-3D™ Tissue Clearing Kit to Accelerate 3D Fluorescence Imaging
St. Louis, MO, 25 April, 2025 - Leinco Technologies, a [...]
Leinco Technologies Awarded $1M Grant to Develop Rapid Test for Intestinal Immunity to Polio
St. Louis, MO, February 6, 2025 - Leinco Technologies, a [...]
Leinco Technologies Welcomes Dr. Stephen T. Haley as Vice President of Business Development
St. Louis, MO, December 3, 2024 - Leinco Technologies is [...]
Leinco Technologies Inc. Acquires QED Biosciences, Leading Provider of Antibodies, Related Reagents, and Development Services
The strategic acquisition will enable Leinco to expand its portfolio [...]
Launch of chimeric anti-mouse PD1 and PD-L1 recombinant antibodies
Leinco Technologies Highlights Launch of the new mAbMods™ chimeric anti-mouse [...]
Antibodies Targeting an Array of Infectious Diseases: Leinco and VUMC Advance Research and Diagnostics
Strategic Collaboration: Leinco Technologies and Vanderbilt University Medical Center ST. [...]
Development of novel COVID-19 diagnostic tools
Leinco Technologies, Inc. and La Jolla Institute for Immunology announce [...]
Leinco receives CODEX® licensing rights
Akoya Biosciences, Inc. and Leinco Technologies, Inc. Announce Strategic Partnership [...]
Strategic Partnership: Leinco Technologies and Vanderbilt University Medical Center
Development of rapid, point of care, immunodiagnostic test for detection [...]
